Clinical Trials Browser

Pleural Effusion, Malignant × Cisplatin × Thoracic × Clear all

NCT04914598 2026-01-02

A Phase Ⅲ Clinical Study of Combined Cisplatin Versus Placebo Combined With Intracavitary Cisplatin Injection in the Treatment of Malignant Pleural Effusions

Phase 3 Active not recruiting

Pleural Effusion, Malignant

NCT00791154 2024-08-23

SCLC

Phase 1/2 Terminated

213 enrolled 16 charts

Lung Neoplasms, Pleural Effusion, Malignant, Small Cell Lung Carcinoma

NCT00993655 2023-08-28

Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer

Phase 2 Completed

275 enrolled 13 charts

GynecologicThoracic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pleural Effusion, Malignant

NCT02657460 2019-02-26

Clinical Trial of Tumor Cell-derived Microparticles Packaging Chemotherapeutic Drugs to Treat Malignant Pleural Effusion

Phase 2 Unknown

Pleural Effusion, Malignant

NCT02407912 2015-11-20

Cisplatin for Malignant Pleural Effusion in Patients With Non-small-cell Lung Cancer

Phase NA Unknown

Pleural Effusion, Malignant

NCT02429726 2015-04-29

Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural Effusion

Phase 2 Unknown

Pleural Effusion, Malignant

NCT01661790 2015-03-25

Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer

Phase 3 Completed

72 enrolled 5 charts

Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

NCT01327235 2014-08-01

Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites

Phase 2 Completed

Pleural Effusion, Malignant